Christine Stanley
About Christine Stanley
Christine Stanley serves as the Clinical Laboratory Director at C2i Genomics and has extensive experience in the biotechnology industry, specializing in Minimal Residual Disease (MRD) cancer recurrence. She holds a Ph.D. in Human Genetics and has held various leadership roles in clinical laboratories throughout her career.
Work at C2i Genomics
Christine Stanley serves as the Clinical Laboratory Director at C2i Genomics, a position she has held since 2018. In this role, she oversees laboratory operations and ensures the delivery of high-quality genomic testing services. Her expertise in Minimal Residual Disease (MRD) cancer recurrence informs the laboratory's focus on precision medicine and cancer genomics. C2i Genomics is located in Cambridge, MA, where Stanley applies her extensive experience in the biotechnology sector to advance the company's clinical laboratory capabilities.
Education and Expertise
Christine Stanley holds a Ph.D. in Human Genetics from Virginia Commonwealth University, where she studied from 1996 to 2002. She also completed a Clinical Molecular Genetics Fellowship Program at Boston University School of Medicine from 2001 to 2004. Her educational background provides a strong foundation in genetics, which is complemented by her expertise in Minimal Residual Disease (MRD) cancer recurrence. This specialized knowledge positions her as a leader in the field of clinical genomics.
Background in Biotechnology
Christine Stanley has a demonstrated history of working in the biotechnology industry, with experience spanning various roles and organizations. Prior to her current position, she served as the Head of Clinical Laboratory at WuXi NextCODE and as Medical Director of QnA Diagnostics from 2017 to 2019. She also held the role of Chief Laboratory Director at Courtagen Life Sciences, Inc. from 2013 to 2017. Her diverse background reflects a commitment to advancing genomic technologies and laboratory management.
Previous Roles and Experience
Before her tenure at C2i Genomics, Christine Stanley worked in several key positions. She was the Laboratory Director at Athena Diagnostics from 2007 to 2013 and served as an Instructor at Virginia Commonwealth University from 1998 to 2000. Additionally, she has been involved in leadership roles at various organizations, including her current position as Chief Director of Clinical Genomics at Variantyx since 2019. This breadth of experience contributes to her strong skills in result reporting and laboratory management.